A polyclonal antibody was generated using synthetic peptides designed in a specific sequence of the rat D 3 receptor (D 3 R). Using transfected cells expressing recombinant D 3 R, but not D 2 receptor, this antibody labeled 45-80 kDa species in Western blot analysis, immunoprecipitated a soluble fraction of [
A polyclonal antibody was generated using synthetic peptides designed in a specific sequence of the rat D 3 receptor (D 3 R). Using transfected cells expressing recombinant D 3 R, but not D 2 receptor, this antibody labeled 45-80 kDa species in Western blot analysis, immunoprecipitated a soluble fraction of [
125 I]iodosulpride binding, and generated immunofluorescence, mainly in the cytoplasmic perinuclear region of the cells. In rat brain, the distribution of immunoreactivity matched that of D 3 R binding, revealed using [
125 I]R(ϩ)trans-7-hydroxy-2-[N-propyl-N-(3Ј-iodo-2Ј-propenyl)amino] tetralin ([ 125 I]7-trans-OH-PIPAT), with dense signals in the islands of Calleja and mammillary bodies, and moderate to low signals in the shell of nucleus accumbens (AccSh), frontoparietal cortex, substantia nigra (SN), ventral tegmental area (VTA) and lobules 9 and 10 of the cerebellum. Very low or no signals could be detected in other rat brain regions, including dorsal striatum, or in D 3 R-deficient mouse brain. Labeling of perikarya of AccSh and SN/VTA appeared with a characteristic punctuate distribution, mostly at the plasma membrane where it was not associated with synaptic boutons, as revealed by synaptophysin immunoreactivity. In SN/VTA, D 3 R immunoreactivity was found on afferent terminals, arising from AccSh, in which destruction of intrinsic neurons by kainate infusions produced a loss of D 3 R binding in both AccSh and SN/VTA. D 3 Rimmunoreactivity was also found in all tyrosine hydroxylase (TH)-positive neurons observed in SN, VTA and A8 retrorubral fields, where it could represent D 3 autoreceptors controlling dopamine neuron activities, in agreement with the elevated dopamine extracellular levels in projection areas of these neurons found in D 3 R-deficient mice.
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Converging pharmacological, genetic and human postmortem studies have implicated the D 3 receptor (D 3 R) in the physiopathology and treatment of schizophrenia, drug addiction and depression (Pilla et al., 1999; Lammers et al., 2000; Schwartz et al., 2000) . In rat brain, the largest D 3 R expression densities occur in granule cells of the islands of Calleja and in medium-sized spiny neurons of the rostral and ventromedial shell of nucleus accumbens (AccSh), which coexpress the D 1 receptor and neuropeptides (Diaz et al., 1994; Diaz et al., 1995; Le Moine and Bloch, 1996) . The neurons from AccSh receive their dopaminergic innervation from the ventral tegmental area (VTA) and other innervations from cerebral cortex, hippocampus and amygdala (Zahm and Brog, 1992; Pennartz et al., 1994) , project indirectly to entorhinal and prefrontal cortice and subserve the control of emotion, motivation and reward (Willner and Sheel-Krüger, 1991) .
One aspect of the localization and function of the D 3 R that is still highly debated is its occurrence as an autoreceptor, regulating the activity of dopamine neurons. We originally proposed the existence of D 3 autoreceptors on the basis of the expression in substantia nigra (SN) and VTA of D 3 R mRNA, which strongly decreases after lesion of dopamine neurons (Sokoloff et al., 1990) . This lesion, however, also downregulates postsynaptic D 3 R in AccSh , by deprivation of brain-derived neurotrophic factor (BDNF), an anterograde factor of dopamine neurons (Guillin et al., 1999) . Hence the lesion-induced decrease in SN/VTA could reflect a similar process occurring in nondopaminergic neurons.
Dopamine release (Tang et al., 1994) and synthesis (O'Hara et al., 1996) are inhibited by stimulation of the D 3 R expressed in a transfected mesencephalic cell line and various agonists, with limited preference for the D 3 R (Sautel et al., 1995) , inhibits dopamine release, synthesis and neuron electrical activity (for review, see Levant, 1997) , giving support to the existence of D 3 autoreceptors. However, the selectivity of these agonists toward the D 3 R in vivo is strongly questioned, because they elicit similar inhibition of dopamine neuron activities in wild-type and D 3 R-deficient mice (Koeltzow et al., 1998) . In addition, dopamine autoreceptor functions are suppressed in D 2 receptor-deficient mice (Mercuri et al., 1997; L'hirondel et al., 1998) . Nevertheless, dopamine extracellular levels in the nucleus accumbens (Koeltzow et al., 1998) and striatum (R. Gainetdinov and M. G. Caron, personal communication) are twice as high in D 3 R-deficient as in wild-type mice, suggesting a control of dopamine neurons activity by the D 3 R.
Direct confirmation of the role of the D 3 R as an autoreceptor requires the demonstration of its occurrence in dopamine neurons, namely by using immunocytochemical methods. In fact, the antibodies directed against the D 3 R reported so far generated immunolabeling that did not overlap distributions of D 3 R mRNA and binding sites (Ariano and Sibley, 1994; Larson and Ariano, 1995; Khan et al., 1998) , which questions their specificity. In the present study, we have generated a polyclonal antibody against the D 3 R using sequence-specific peptides and assessed its specificity using recombinant receptors and D 3 R-deficient mice and by comparison with D 3 R binding. This antibody has then been used to examine cellular localizations of the D 3 R by comparison with tyrosine hydroxylase (TH) and synaptophysin immunoreactivities.
MATERIALS AND METHODS
Immunization, antiserum titration and antibody purification. The immunization procedure conformed with local guidelines and has been performed by a person accredited by the French Minister of Agriculture (decree 87848). The peptide H-YGAGMSPV ERTRNSL -OH (Y15L) was coupled by copulation with diazotized benzidine to bovine serum albumin (BSA) and subcutaneously injected together with complete Freund's adjuvant once, and then with the incomplete Freund's adjuvant each week for 4 weeks (268 g of peptide per injection), into female New Z ealand rabbits. A booster injection in complete Freund's adjuvant was performed one month latter with the same immunogen. The peptide Y15L was coupled to keyhole Limpet hemocyanin and used for a booster injection (500 g of the peptide) 3 months later. Three months later, the rabbits were injected with the peptide H-GAGMSPV ERTRNSLY-OH (G15Y) coupled by copulation via bisdiazobenzidine to ovalbumin. Five booster injections with the latter peptide (350 g of peptide/injection) were made during the 3 years that followed. Rabbits were bled every 1-4 weeks and serum titer was assayed using [
125 I]tyrosyl-labeled G15Y or Y15L and polyethyleneglycol precipitation.
The best titer antiserum collected at the end of the immunization procedure was precipitated with ammonium sulfate, filtered on DEAESephadex and immunopurified on a HiTrap column (Amersham Pharmacia Biotech, Little Chalfont, UK) coupled to peptide G15Y by the amino group. The purified antibody was eluted in glycine-HC l 0.1 M, pH 2.3.
Western blot anal ysis. Wild-type and transfected Chinese hamster ovary (CHO) cells expressing the D 2 receptor or D 3 R (Sokoloff et al., 1990) were scrapped, harvested in 50 mM sodium phosphate buffer (PB) containing 150 mM NaC l (PBS), and homogenized in Tris-HC l buffer, 10 mM containing 5 mM EDTA and protease inhibitors (aprotinin, 1 g /ml; leupeptin, 1 g /ml; pepstatin, 0.1 g /ml). Membranes were isolated by centrif ugation at 5000 ϫ g for 10 min and solubilized in PAGE-loading buffer (50 mM Tris-HC l, pH 7.4, 5 mM EDTA, 10% glycerol, 2% SDS, protease inhibitors as above). Proteins (20 g) were separated by electrophoresis in 12% SDS-polyacrylamide gel and electrophoretically transferred to nitrocellulose filters. Blots were blocked in PBS Blotto (Pierce, New York, N Y) with 1% bovine serum albumin at room temperature for 2 hr. The blots were then incubated with purified anti-D 3 R antibody (1:2000) overnight at 4°C. After three 10 min washes in PBS containing 0.05% T ween 20, blots were incubated with a horseradish peroxydase-conjugated goat anti-rabbit ␥-globulins antibody (1:10,000, Pierce) for 1 hr at room temperature and developed using the enhanced chemiluminescence procedure (Amersham Pharmacia Biotech).
Receptor immunoprecipitation. Membranes of CHO cells expressing the D 2 receptor or D 3 R were solubilized in 1% digitonin, 1% sodium cholate, and 1 M NaCl in 50 mM sodium phosphate buffer, pH 7.4, for 30 min at 4°C, diluted twice in sodium phosphate buffer, and centrif uged for 30 min at 50,000 ϫ g. Supernatants (100 l) diluted 10 times in sodium phosphate buffer were incubated in a final volume of 400 l with diluted preimmune serum or antiserum and [
125 I]iodosulpride (0.1 nM, 2200 C i /mmol) (Amersham) overnight at 4°C. Some incubations were performed with the antibody previously presaturated overnight with the peptide G15Y (1 g/l), and some were performed in the presence of 1 M emonapride to measure nonspecific binding. Fifty microliters of a 50% (v/ v) suspension of protein A-Sepharose (Amersham Pharmacia Biotech) were added, and tubes were incubated under gentle agitation for 2 hr at 4°C and then centrif uged for 3 min at 14,000 rpm. Aliquots of supernatants were filtered through GF/ B filters coated with 0.3% polyethyleneimine, and filters were rinsed with 3 ϫ 3 ml of cold sodium phosphate buffer. In preliminary experiments, this procedure allowed us to solubilize and recover up to 20% of membrane-bound receptors.
Animals, tissue, and cell preparation for immunohistochemistr y and immunofluorescence. Male Wistar rats (180 -250 gm, Iffa-Credo, L'Arbresles, France) or mice (see below) were anesthetized deeply with pentobarbital (30 mg / kg, i.p.) and then perf used transcardially with 50 ml of saline solution (0.9% NaC l warmed at 37°C), followed by 600 ml of an ice-cooled fixative solution containing 2% paraformaldehyde in 0.1 M PB, pH 7.5. The brains were removed, post-fixed in 2% paraformaldehyde for 1-2 hr at 4°C, and rinsed in PB solutions. Some brains were transferred into ascending series of sucrose solutions (10% overnight, 15% for 24 hr, and 20% for 24 hr), frozen and stored at Ϫ70°C, and then sectioned in coronal and sagittal planes with a cryostat in 30 m sections. Other brains were immediately cut in the same planes with a vibratome in 40 m sections that were collected, cryoprotected in PB containing 30% sucrose, and freeze-thawed (Ϫ75°C) to improve penetration of the antibodies. Cryostat or vibratome sections were collected in 0.05 M Tris buffer, pH 7.5, containing 150 mM NaC l (TBS) and then treated with blocking serum (5% normal donkey serum, 0.4% BSA, 0.1% gelatin, and 0.1% T ween 20 in TBS) for 1 hr at room temperature. CHO cells were cultured on 20 ϫ 20 mm collagencoated slides, rinsed with PBS, fixed for 30 min in 2% paraformaldehyde, rinsed again in 0.1 M glycine -PBS, and immersed in the blocking serum as above.
Detection of D 3 R immunoreactivit y by the immunoperoxidase method. The sections were incubated for 24 -48 hr at room temperature with the immunopurified anti-D 3 receptor antibody diluted 1:2000 in TBS containing 5% normal donkey serum and 0.05% T ween 20 (TBS -N DST20). Some sections were incubated with the antibody previously presaturated overnight with the peptide G15Y (1 g/l). The sections were rinsed (four times for 10 min) in TBS containing 0.1% gelatin and 0.05% T ween 20 (TBS -GT20) and immersed for either 1-2 hr at room temperature or overnight at 4°C in biotinylated donkey anti-rabbit ␥-globulins (Amersham) diluted 1:200 in TBS -N DST20. The sections were rinsed (three times for 10 min) in TBS -GT20 and then incubated for 1 hr at room temperature in avidin -biotin -HRP complex (ABC reagent, VectastinElite; Vector Laboratories, Burlingame, CA). After rinsing in TBS containing T ween 20 (0.05%) and then in TBS, peroxidase activity was revealed by incubation with 3,3Ј diaminobenzidine for 10 -30 min at 4°C in the presence of hydrogen peroxide using the Sigma Fast diaminobenzidine tablets (Sigma, St. L ouis, MO). The peroxidase reaction was stopped by several rinses in Tris-HC l. The sections were mounted on glass slides, dehydrated in graded ethanols, cleared, and then mounted in Acrytol for observation under a Z eiss Axiophot microscope.
Immunofluorescence e xperiments. Vibratome coronal sections taken at levels of both basal forebrain (nucleus accumbens-ventral pallidum) and midbrain (V TA-SN) regions were incubated for 24 -48 hr at room temperature in a mixture of primary immunoreagents diluted in TBS -N DST20. The mixture consisted of purified anti-D 3 R antibody diluted 1:2000 and mouse monoclonal antibodies directed against either synaptophysin (diluted 1:50) (Boehringer Mannheim Biochemica, Mannheim, Germany) or anti-TH (diluted 1:10,000) (Incstar, Stillwater, M N). Slides with fixated CHO cells were incubated for 48 hr at 4°C with the purified anti-D 3 R antibody only, diluted 1:2,000. After four washes (10 min each) in TBS -GT20, the sections were incubated in FI TC -donkey anti-mouse (Jackson Immunoresearch, West Grove, PA) diluted 1:200 in TBS -N DST20, followed by C y3-donkey anti-rabbit ␥-globulins (Jackson Immunoresearch), diluted 1:1000 in TBS -N DST20, for 1 hr at room temperature. To intensif y the D 3 R fluorescent immunostaining, some double-labeling experiments were performed using a biotinylated donkey anti-rabbit IgG (1:200 in TBS -N DST20) followed by three washes (10 min each) and incubation for 1 hr in C y3-streptavidin (0.5 g /ml in TBS -T20). The sections were washed (three times for 10 min), mounted on Super Frost Plus slides, and then coverslipped using Vectashield mounting medium (Vector Laboratories) and nail polish to seal the coverslip. Sections were examined and photographed using Z eiss Plan-Neofluar objectives and band-pass filter sets for FI TC and rhodamine. Control experiments were performed to ensure that each primary antibody did not react with the non-corresponding secondary antibody-conjugate. In such experiments, sections were incubated as follows: rabbit anti-D 3 R antibody, followed by FI TC -donkey anti-mouse or mouse anti-TH followed by C y3-donkey anti-rabbit. In these controls, only light autofluorescence and no cross-reactive immunostaining were observed. D 3 R-deficient mice. Heterozygotous mice bearing a mutation invalidating the D 3 R gene, originally obtained from S. Fuchs (Weizmann Institute, Rehovot, Israel) (Accili et al., 1996) , were bred and mated. DNA was prepared from a piece of the tail (3-5 mm) using the DNAeasy tissue kit (Qiagen France, Courtaboeuf, France) and amplified with the mixture of primers GCA GTG GTC ATG CCA GTT CAC TAT CAG and CC T GTT GTG TTG AAA CCA AAG AGG AGA GG, amplif ying the exon 3 of the wild-type D 3 R, and TGG ATG TGG AAT GTG TGC GAG and GAA ACC AAA GAG GAG AGG GCA GGA C, amplif ying the PGK cassette of the mutated gene. Agarose gel electrophoresis allowed us to detect homozygotous wild-type mice (a single band at 137 bp), homozygotous mutated mice (a single band at 200 bp), and heterozygotous mice (bands at 137 and 200 bp). Homozygotous mutated mice and their wild-type littermates were used in the study.
Lesion studies. Male Sprague Dawley rats (180 -200 gm, Iffa Credo, L'Arbresles) were anesthetized with pentobarbital (50 mg / kg). Nucleus accumbens lesions were made by inf usion of kainate (1.5 l of a solution at 2.5 g /ml in 25 mM Tris-HC l buffer, pH 7.4, at the following coordinates: anterior-posterior ϩ1.7 mm; lateral Ϫ1 mm; ventral Ϫ7 mm from the dural surface. The inf usion cannula was left in position for 3 min after each one-side inf usion. Animals were killed 10 d after stereotaxic surgery. Assessment of the placement and extent of the lesion was performed under microscopic observation of Nissl-stained sections.
Receptor autoradiography. Unfixed 10 m cryostat brain sections were preincubated at room temperature three times for 5 min in 50 mM sodium-H EPES buffer, pH 7.5, containing 1 mM EDTA and 0.1% BSA. They were incubated in the same buffer containing 0.2 nM [
125 I]R(ϩ)trans-7-hydroxy-2-[N-propyl-N-(3Ј-iodo-2Ј-propenyl)amino] tetralin ([ 125 I]trans-7-OH-PI-PAT; 2200 C i /mmol; Amersham) for 45 min at room temperature. Nonspecific binding was determined by incubating adjacent sections in the same medium in the presence of 1 M dopamine. After incubation, slices were washed four times for 2 min in ice-cold sodium-H EPES buffer containing 100 mM NaC l, dipped in ice-cold distilled water, and then dried under a stream of cold air. Autoradiograms were generated by apposing sections to 3 H-Hyperfilm (Amersham) for 2-4 d and developed in D-19 developer. Autoradiographic signals were quantified on two to three slices per animal using an image analyzer (IMSTAR, Paris, France). Gray values were converted to microcuries per gram wet weight using 125 I standard stripes (Amersham).
In situ hybridization. The procedure has been described previously . Briefly, paraformaldehyde-fixed slices (10 m) were treated with proteinase K (1 g /ml) and then with 0.25% acetic anhydride in triethanolamine buffer. The sections were hybridized with a 33 Pradiolabeled cRNA probe for D 3 R mRNA (2 ϫ 10 6 dpm per slide) in 65% deionized formamide, 10% dextran sulfate, 1ϫ Denhardt's solution, 2ϫ SSC, 0.1% sodium pyrophosphate, 100 g /ml yeast tRNA, and 100 g /ml denatured salmon sperm DNA. After incubation and rinsing, slices were treated with RNase A (200 g /ml), washed and dehydrated through a graded series of ethanol, and apposed to films (Hyperfilm ␤-max, Amersham) for 1 month. Films were developed in D-19 developer (15°C) for 5 min, rinsed rapidly in deionized water, and fixed in 30% sodium thiosulfate for 10 -20 min.
RESULTS

Generation of anti-D 3 R antibodies
The immunizing peptide sequence was designed in the putative third intracytoplasmic loop of the rat D 3 R, which has no homologies with the sequence of other dopamine receptor subtypes (Fig.  1 A) . A portion of this sequence has a strong homology with the human D 3 R. A search in databases did not reveal any other homology with a known protein. A first peptide, Y15L, had an additional tyrosine residue at the N terminus, allowing coupling to the carrier tyrosines with diazotized benzidine, and was used to immunize rabbits. After the initial immunization and a booster injection, rabbits were subsequently boosted with a second peptide, G15Y, having the same sequence, but with the additional tyrosine used for coupling located at the C terminus instead of the N terminus. Immunoreactivity of the antisera was measured with the two peptides [ 125 I]-labeled at either the C or N terminus (Fig. 1 B) .
Although immunoreactivity against [
125 I]Y15L raised and reached a similar antiserum titer after each booster injection, immunoreactivity against [
125 I]G15Y appeared only after G15Y injections, and its titer increased progressively thereafter. At the end of immunization, antisera titers were similar against the two iodinated peptides. Furthermore, antibodies had similar affinities for Y15L and G15Y (EC 50 ϭ 0.5 nM; data not shown), as well as a shorter peptide S10L (see sequence on Fig. 1 A) , indicating that antibodies indeed recognized internal epitopes.
Characterization of antibodies using recombinant dopamine receptors
In crude membrane preparations of CHO cells expressing the D 3 R that were subjected to SDS-PAGE, the immunopurified antibody labeled major bands at ϳ45 and ϳ80 kDa (Fig. 2 A) . Minor bands, possibly corresponding to degraded proteins, were also visible at ϳ60 kDa and below 35 kDa. All of these bands were absent when the antibody was presaturated with the immunizing peptide G15Y. No signal could be detected with membranes from wild-type or D 2 receptor-expressing CHO cells. Strong immunofluorescence signals generated with an immunopurified antibody were detected on D 3 R-expressing CHO cells, but not on wild-type nor D 2 receptor-expressing CHO cells (Fig. 2C) . Most of the signal appeared in the cytoplasm of D 3 R-expressing cells, particularly in the perinuclear region, but some cells also displayed immunofluorescence at the plasma membrane (Fig. 2C,  arrow) . No signal could be detected when the D 3 R antibody was omitted or presaturated with the immunizing peptide (data not shown).
Distribution of D 3 receptor immunoreactivity in rat and wild-type or D 3 receptor-deficient mouse brains
In rat brain slices, there was a close overlap between the distributions of D 3 R immunoreactivity, revealed by immunoperoxidase, and binding sites for [
125 I]trans-7-OH-PIPAT, a D 3 R-selective ligand (Burris et al., 1994) . Thus, highest immunoreactivity levels were found in the islands of Calleja (Fig. 3B) , which also express the highest density of D 3 R mRNA (Bouthenet et al., 1991; . Strong labeling was also observed in AccSh. A much weaker signal was observed in the core of nucleus accumbens (Fig.  3B) , a region where D 3 R mRNA and binding levels are weak (Fig.  3A) (Bouthenet et al., 1991; Diaz et al., 1995) . In normal D 3 R ϩ/ϩ mouse brain, the D 3 R immunolabeling was similar to that found in rat brain and undetectable in D 3 R-deficient mouse brain (Fig.  3 D, E) .
A semiquantitative comparison between D 3 R immunoreactivity, binding, and mRNA levels in rat brain (Table 1) shows an overall agreement between distributions of the three markers. For instance, a high level of D 3 R immunoreactivity was found in mammillary bodies, a region expressing high levels of D 3 R binding and mRNA (Bouthenet et al., 1991) , whereas a much weaker signal was observed in dorsolateral striatum, where the latter markers are hardly detectable. Moderate signals were observed in the frontoparietal cortex, ventral pallidum, anteroventral thalamic nucleus, and lateral habenula, which also express D 3 R binding (Table 1) , whereas other brain regions contained very low or undetectable levels of both D 3 R immunoreactivity and binding. The only discrepancy was found in the cerebellum, where high levels of D 3 R binding and mRNA are present in lobules 9 and 10 (Bouthenet et al., 1991; Diaz et al., 1995) , whereas weaker D 3 R immunoreactivity was observed (Table 1) . This suggested that the D 3 R may differ in cerebellum and other brain regions, but cDNAs amplified from mRNAs extracted from cerebellar lobules 9 and 10 and from nucleus accumbens had identical sequences, notably in the region corresponding to the immunizing peptide (data not shown).
D 3 receptor immunoreactivity in the mesencephalon
Moderate D 3 R immunoreactivity, revealed by the immunoperoxidase method, was found in the rat SN/VTA complex, where individual cell bodies were clearly visualized in all parts of the complex (Fig. 3 H, J ) . Enlargement shows labeling of individual cell bodies in the SN pars compacta (Fig. 3J ) . The immunoreactivity was abolished by presaturation of the antibody with the immunizing peptide G15Y (Fig. 3 I, K ) . In contrast, [
125 I]trans-7-OH-PIPAT binding was prominent in a restricted part of the complex, at the junction between SN pars compacta and VTA (Fig. 3F ) , and did not overlap the highest D 3 R mRNA densities (Fig. 3G). [
125 I]trans-7-OH-PIPAT binding in this area indeed labeled the D 3 R, because this binding was completely absent in D 3 R-deficient mice (Fig.  4 A, B) . D 3 R immunoreactivity, revealed by the immunoperoxidase method in SN/VTA, was largely absent in D 3 R-deficient mice (Fig.  4C,D) , and the characteristic punctuate distribution of D 3 R immunofluorescence in neurons of VTA was completely absent in these mice (Fig. 4 E, F ) . In addition, D 3 R immunoreactivity, binding, and mRNA were present in the A8 retrorubral dopamine cell group in the rat (Table 1) .
To investigate the possibility that a fraction of D 3 R binding in SN/VTA was present on afferent fibers from extrinsic neurons, we performed lesions of neurons intrinsic to AccSh by local infusions of kainate. Ten days later, this lesion elicited disappearance of Nissl-stained cells centered in the shell part of nucleus accumbens, but extended to the core part of nucleus accumbens and medioventral striatum (data not shown). No signs of trans-synaptic degeneration were observed: intrinsic neurons present in SN/VTA were apparently normal in number and shape (data not shown). The lesion elicited large and identical decreases (Ϫ62 and Ϫ63%, respectively) in D 3 R binding in both the lesioned area and ipsilateral SN/VTA (Fig. 5 A, B) .
Comparison of D 3 receptor and tyrosine hydroxylase immunofluorescences
To assess the occurrence of D 3 autoreceptors, double-labeling experiments with antibodies directed against the D 3 R and TH were (Fig. 6 A, B) , distributions of D 3 R and TH immunofluorescences were overlapping in the SN pars compacta and VTA but not in SN pars reticulata and SN pars lateralis, where most D 3 R-positive cells were TH negative. Microscopic examination of every section from 10 animals (15-20 sections per animal) at high magnifications (see representative examples in Fig.  6C-F ) indicated that all TH-positive cells also displayed D 3 R immunofluorescence; we could not find any TH-positive cell not expressing D 3 R immunofluorescence in SN and VTA. In contrast, some D 3 R-positive cells (a few of them are designated by arrows in Fig. 6 D) did not display TH immunofluorescence. At the highest magnification used (Fig. 6 E, F ) , there were clearly distinct cellular localizations of the two immunofluorescences: D 3 R immunofluorescence appeared with a characteristic punctuate distribution at the plasma cell membrane and within the cytoplasm, whereas TH immunofluorescence was homogeneously distributed in the cytoplasm. Both immunofluorescences were absent from the cell nucleus. In addition, on a limited number of sections (n ϭ 3) taken at the level of the retrorubral A8 dopamine cell group, we also observed that all TH-positive cells also displayed D 3 R immunofluorescence (data not shown).
In AccSh, D 3 R immunofluorescence also appeared with a punctuate distribution at the plasma membrane of cell bodies and within the neuropil (Fig. 6G) . TH immunofluorescence was mainly distinct from D 3 receptor immunofluorescence, with very rare apparent coincidences (Fig. 6 H) .
Comparison of D 3 receptor and synaptophysin immunofluorescences
To assess whether the D 3 R immunofluorescence was localized at the vicinity of synaptic components, we compared distributions of D 3 R and synaptophysin immunofluorescences in AccSh (Fig. 6 I) , islands of Calleja (Fig. 6 J) , and VTA (Fig. 6 K) . The punctuate distribution of D 3 R immunofluorescence both in the cell bodies, mostly near the plasma membrane, and in the neuropil in the three regions did not correspond to the distribution of synaptophysin immunofluorescence, and only few apparent coincidences could be found.
DISCUSSION
Many studies have used antibodies raised against carrier-coupled synthetic peptides, the sequence of which is chosen in unique and predicted antigenic regions of the target protein. The antibodies raised in this manner are likely to recognize mainly the free, not the coupled, extremity of the peptide, which is a valuable strategy Bouthenet et al. (1991) and Diaz et al. (1995) . if the chosen sequence is at the N or C termini of the target protein, but a possible drawback if the sequence is internal. In the case of the D 3 R, the N-terminal sequence has several putative sites for N-glycosylation, which may hinder recognition of the native protein, and the C terminus displays significant homologies with D 2 and D 4 receptor corresponding sequences. Hence, we decided to generate antibodies by using a synthetic peptide taken at the level of the third intracytoplasmic loop, coupled to the carrier by its N terminus, and then using a peptide having the same sequence but coupled by its C terminus. As expected, this strategy indeed favored generation of antibodies recognizing internal epitopes, because these antibodies display similar titer and affinity for the immunizing peptides, whether they are [ 125 I]tyrosyl-labeled at the C or N terminus. The immunopurified antibody also binds to denatured as well as native recombinant D 3 R expressed by transfected CHO cells. The major immunoreactive species are ϳ40 and 80 kDa in size, and the smallest species may correspond to a degraded, incompletely synthesized, or nonglycosylated form (M r 45,500 Da deduced from the predicted amino acid sequence), whereas the largest species may correspond to either SDS and reduction-resistant dimers or glycosylated forms. The species at ϳ80 kDa have the same apparent size as D 2 /D 3 receptor binding sites labeled with photoaffinity radioligands using brain tissue homogenates (Amlaiky and Caron, 1985; Redouane et al., 1985) , suggesting the largest as the active form. This hypothesis needs confirmation, however, because we could not reliably measure the apparent size of the native D 3 R from rat brain, which is not surprising given its very low expression level: 10 -100 times lower than that of the D 2 receptor (Lévesque et al., 1992) .
Thus, in transfected CHO cells, the overexpressed D 3 R recognized by the antibody is largely present as immature or degraded protein, which is in agreement with its main occurrence in the cytoplasm, particularly in the perinuclear region of the cell. This cellular localization markedly contrasts with that found in neurons, where the D 3 R is apparently mainly present at the plasma membrane, with only few occurrences as cytoplasmic patches, probably associated with recycling or synthesizing vesicles. In addition, the antibody recognizes recombinant solubilized D 3 R, in an active form able to bind a radioligand and precipitable by immobilized protein A. This antibody would therefore be a valuable tool for studying the D 3 R regulation, e.g., phosphorylation.
In rat brain sections, the pattern of immunolabeling matched that of D 3 R binding and transcripts, with highest levels present in the islands of Calleja and mammillary bodies, moderate to low levels in AccSh, frontoparietal cortex, lobules 9 and 10 in cerebellum, and SN/VTA, and very low levels in other brain structures including striatum. The observation that immunolabeling and D 3 R binding patterns overlap is a strong criterion for assessing the specificity of this antibody, which was apparently not fulfilled in previous studies. In the latter, the specificity of the antibodies used was questionable because highest levels of alleged D 3 R-like immunoreactivity were not found in AccSh or islands of Calleja but in striatum and core of nucleus accumbens (Ariano and Sibley, 1994) or in hippocampus (Khan et al., 1998) , which contains low or undetectable levels of D 3 R binding or mRNA. The selectivity of the antibody developed herein is also based on the solid evidence, lacking in previous studies, that the immunolabeling it generates is absent in D 3 R-deficient mice. This antibody therefore appears to have the specificity required for reliable immunocytochemistry.
The only minor discrepancy identified so far is the lowest level of immunolabeling in lobules 9 and 10 of the cerebellum, as compared with D 3 R binding and mRNA. Because we have presently confirmed that the D 3 R in the cerebellum has a sequence identical to that found in the nucleus accumbens, this apparent mismatch could be because of an inappropriate tissue preparation, leading to a loss of accessibility of the antibody or antigenicity in this particular brain area. D 3 R binding is present in dendritic trees of Purkinje cells of the cerebellar molecular layer , which may not be totally preserved by the fixatives. Alternatively, the D 3 R in the cerebellum could partly be in a form not recognized by the antibody. The sequence of the immunizing peptide contains a putative site for casein kinase 2 (S/T-X-X-D/E), a protein kinase very abundant in brain (Blanquet, 2000) . Phosphorylation by this or a similar enzyme activity at this site may hinder recognition by the antibody.
The antibody developed in the present study allowed us to not only confirm the localization of the D 3 R in rat brain but also to address the important issue of its occurrence as an autoreceptor. Three distinct kinds of immunolabeling localization were found in (FITC, green) . I, J, and K show photomicrographs taken at the level of the nucleus accumbens shell, islands of Calleja, and VTA, respectively. In the three regions, D 3 R immunofluorescence has a punctuate distribution at the plasma cell membrane, which segregates in cellular components distinct from those containing synaptophysin. SNc, SN pars compacta; SNl, SN pars lateralis; SNr, SN pars reticulata. Scale bars: A, B, 1 mm; C, D, 125 m; E, F, 25 m; G, H, 10 m; I-K, 15 m.
